Kiniksa Pharmaceuticals International (KNSA) EBITDA Margin (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported EBITDA Margin of 11.36% for Q2 2026, down 1.73 percentage points from 13.09% a year earlier and down 2.52 percentage points from the prior quarter.
Kiniksa Pharmaceuticals International (KNSA) EBITDA Margin (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kiniksa Pharmaceuticals International's EBITDA Margin came in at 12.14%, up 11.01 percentage points year-over-year; for FY2025, it came in at 11.63%, up 22.00 percentage points from FY2024.
- EBITDA Margin has a four-year change of +411.90 percentage points (FY2021 to FY2025).
- By year, EBITDA Margin came in at -10.38% in FY2024 (-1.92 pp), -8.46% in FY2023 (-13.99 pp), 5.53% in FY2022 (+405.80 pp) and -400.27% in FY2021.
- Five-year quarterly EBITDA Margin spans a low of -248.11% in Q3 2021 and a high of 47.32% in Q3 2022.
- Year over year, EBITDA Margin gained in six of the last eight quarters, with an average year-over-year change of +10.40 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q2 2022 (a gain of 447.71 percentage points); the low point was Q3 2023 (a drop of 62.71 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 13.88% (Q1 2026), 10.01% (Q4 2025) and 13.49% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Kiniksa Pharmaceuticals International | 11.87 Bn | 10.61 Bn | 220.03 Mn | 11.36% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.36% |
| Mar 31, 2026 | 13.88% |
| Dec 31, 2025 | 10.01% |
| Sep 30, 2025 | 13.49% |
| Jun 30, 2025 | 13.09% |
| Mar 31, 2025 | 9.88% |
| Dec 31, 2024 | -15.42% |
| Sep 30, 2024 | -8.25% |
| Jun 30, 2024 | 0.29% |
| Mar 31, 2024 | -20.13% |
| Dec 31, 2023 | 0.74% |
| Sep 30, 2023 | -15.40% |
| Jun 30, 2023 | -3.57% |
| Mar 31, 2023 | -21.93% |
| Dec 31, 2022 | 10.74% |
| Sep 30, 2022 | 47.32% |
| Jun 30, 2022 | -69.39% |
| Mar 31, 2022 | -70.41% |
| Dec 31, 2021 | -189.19% |
| Sep 30, 2021 | -248.11% |
Kiniksa Pharmaceuticals International EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();